Navigation Links
Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine

A powerful headache medicine, Dr. Mauskop's Migralex™, developed by a leading neurologist, Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center, is now available to America’s 100 million headache sufferers.

New York (Vocus) December 9, 2009 -- A powerful headache medicine developed by a leading neurologist for his own patients is now available to America’s 100 million headache sufferers, only 29 percent of whom are satisfied with their current headache treatments.

Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center is the creator of Dr. Mauskop’s Migralex™, the strongest combination headache medicine available without a prescription.

Rather than relying on drugs that simply diminish discomfort, Dr. Mauskop’s Migralex™ targets stubborn pain at its source, correcting metabolic imbalances that trigger headaches. This innovative strategy brings quick relief, while freeing patients from the potential complications that accompany many popular medicines.

“I didn’t want my patients to suffer from the serious side effects seen with many headache drugs, problems like agitation, anxiety, insomnia, nausea, muscle cramps and headaches that become even worse,” explains Dr. Mauskop, a long-time headache sufferer himself.

“Headaches can drive you up the wall and make you try all sorts of medications. But sooner or later you’ll probably come to the conclusion that I did, that modern medicine doesn’t always give us what we seek: safe, reliable control over pain.”

Convinced there had to be a better way, Dr. Mauskop launched a 20-year quest to uncover the cause of headaches and to find alternatives to conventional drugs. His breakthrough research, conducted with Drs. Bella and Burton Altura, revealed that many headache sufferers share a common magnesium deficiency that results in a variety of neurochemical abnormalities. These imbalances cause brain and blood vessel changes in the head that trigger pain.

The doctor created a formula that combines precise amounts of quickly dissolving ingredients capable of delivering fast results with minimal side effects.

Those lucky enough to try the new approach quickly dubbed it a “miracle,” “effective” and “excellent.” However, as word of Dr. Mauskop’s research spread to professional journals, fellow physicians, national media outlets, and headache sufferers everywhere, the clamor for the new medication grew. The doctor answered the call with the release of his over-the-counter product on December 10, 2009.

“I introduced this patented medicine because I want to help many more headache sufferers than just my patients,” underlines Dr. Mauskop.

Now, everyone can take two caplets with a full glass of water to experience the relief previously enjoyed only by patients at the respected New York Headache Center.

Dr. Mauskop’s Migralex™ is fast acting, free of sodium, caffeine and preservatives, and is clinically proven to ease headaches brought on by sinus pain, stress, tension, menstruation, and exertion. The formula reduces inflammation, inhibits the clumping together of platelets, relaxes blood vessels and normalizes dozens of chemical reactions, while successfully and rapidly attacking pain.

With Dr. Mauskop’s Migralex™ widely available at the and websites and at select local pharmacies, the product’s originator is thrilled that many more people can enjoy genuine relief.

“There is simply no reason to be sidelined with an awful headache when such a quick, safe and effective medication is available,“ Dr. Mauskop concludes.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip
2. Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain
3. Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
4. Stroke Survivors Improve Walking, Confidence Level and Quality of Life With Breakthrough Device
5. First results from major European patient survey show devastating impact of living with breakthrough cancer pain
6. Instanyl sets new standard in management of breakthrough cancer pain
7. First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain
8. Potential Breakthrough Cancer Treatment Now Available From Vascular Designs
9. Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results
10. Stem Cell Treatment Breakthrough
11. Breakthrough Technology Harnesses Microorganism for Use as Green Bio-Pesticide
Post Your Comments:
Related Image:
Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic ... addition to the devices for sale in the United States. Clarity is a ... 1064 nm Nd:YAG lasers, into a single platform that is easy to own and ...
(Date:12/1/2015)... ... ... With FCPX Overlay: Grit , users can apply a grit effect ... truly endless, all with a click of a mouse. Each user has full control ... of field and more, all within Final Cut Pro X. , With FCPX Overlay: ...
(Date:11/30/2015)... India (PRWEB) , ... November 30, 2015 , ... ... dental search engine optimization companies, announced today that it has officially launched a ... Third Molar SEO, explained that his company’s new website clearly outlines the benefits ...
(Date:11/30/2015)... ... 2015 , ... The National Association of Professional Women (NAPW) honors ... Year Circle. She is recognized with this prestigious distinction for leadership in estate sales ... more than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to ...
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. ... in the MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was ... a BMI of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  InCarda ... the development and commercialization of therapies for cardiovascular conditions ... established a subsidiary business in Australia ... clinical trial in Australia in ... with leading investigators and medical centers in ...
(Date:12/1/2015)... and TELTOW, Germany , December ... (SMI) , a leading global manufacturer of eye and ... has included SMI remote eye trackers as a ... healthcare providers assess concussions, eye sight, and medical and ... -oem technology is part of SMI,s mass-market-ready eye tracking ...
(Date:12/1/2015)... -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced ... 2016 as the ex-distribution date for Ampio,s previously announced ... Stock of Aytu BioScience, Inc. As announced, Ampio will ... every five (5) shares of Ampio Common Stock owned ... date will be January 4, 2016. ...
Breaking Medicine Technology: